Advertisement
Research Article

Changes in Drug Utilization during a Gap in Insurance Coverage: An Examination of the Medicare Part D Coverage Gap

  • Jennifer M. Polinski mail,

    jpolinski@partners.org

    Affiliations: Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • William H. Shrank,

    Affiliations: Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Haiden A. Huskamp,

    Affiliation: Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Robert J. Glynn,

    Affiliations: Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America, Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America

    X
  • Joshua N. Liberman,

    Affiliation: CVS Caremark, Hunt Valley, Maryland, United States of America

    X
  • Sebastian Schneeweiss

    Affiliations: Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Published: August 16, 2011
  • DOI: 10.1371/journal.pmed.1001075

Reader Comments (0)

Post a new comment on this article